U.S. markets closed

Cyclacel Pharmaceuticals, Inc. (CYCC)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
4.0500-0.0100 (-0.25%)
At close: 4:00PM EDT

4.0500 0.00 (0.00%)
After hours: 4:56PM EDT

Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Premium required to access monthly data
Subscribe to Premium to download historical data
As of Date: 10/16/2020
Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 6

Trading Information

Stock Price History

Beta (5Y Monthly) 1.10
52-Week Change 3-42.43%
S&P500 52-Week Change 314.38%
52 Week High 319.6000
52 Week Low 33.1900
50-Day Moving Average 33.6606
200-Day Moving Average 34.5530

Share Statistics

Avg Vol (3 month) 3221.82k
Avg Vol (10 day) 3201.78k
Shares Outstanding 54.86M
Float 4.46M
% Held by Insiders 15.32%
% Held by Institutions 114.24%
Shares Short (Sep 29, 2020) 453.52k
Short Ratio (Sep 29, 2020) 40.41
Short % of Float (Sep 29, 2020) 41.11%
Short % of Shares Outstanding (Sep 29, 2020) 41.10%
Shares Short (prior month Aug 30, 2020) 429.43k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jul 31, 2016
Ex-Dividend Date 4N/A
Last Split Factor 21:20
Last Split Date 3Apr 14, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Jun 29, 2020


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-25.80%
Return on Equity (ttm)-35.88%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-4.66M
EBITDA -10.02M
Net Income Avi to Common (ttm)-7.79M
Diluted EPS (ttm)-4.8460
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)25.34M
Total Cash Per Share (mrq)5.21
Total Debt (mrq)1.08M
Total Debt/Equity (mrq)4.07
Current Ratio (mrq)18.47
Book Value Per Share (mrq)5.46

Cash Flow Statement

Operating Cash Flow (ttm)-7.78M
Levered Free Cash Flow (ttm)-6.39M